13-32311307-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136571.2(ZAR1L):c.619G>A(p.Ala207Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 1,548,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136571.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZAR1L | NM_001136571.2 | c.619G>A | p.Ala207Thr | missense_variant | 3/6 | ENST00000533490.7 | NP_001130043.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZAR1L | ENST00000533490.7 | c.619G>A | p.Ala207Thr | missense_variant | 3/6 | 5 | NM_001136571.2 | ENSP00000437289 | P1 | |
ZAR1L | ENST00000345108.6 | c.619G>A | p.Ala207Thr | missense_variant | 1/4 | 1 | ENSP00000344616 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000331 AC: 5AN: 151198Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 80462
GnomAD4 exome AF: 0.0000208 AC: 29AN: 1396824Hom.: 0 Cov.: 31 AF XY: 0.0000174 AC XY: 12AN XY: 688918
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | The c.619G>A (p.A207T) alteration is located in exon 1 (coding exon 1) of the ZAR1L gene. This alteration results from a G to A substitution at nucleotide position 619, causing the alanine (A) at amino acid position 207 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at